High-grade Glioma
📧 Sign up to get email alerts when something new happens for High-grade Glioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-02-10Clinical Trial Update: HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma [Phase 2]
A Phase 2 trial evaluating HSV G207 with a single radiation dose for children with recurrent high-grade glioma has been withdrawn from Clini…
-
CLINICAL_TRIALS withdrawal · 2025-07-23Clinical Trial Update: Safety, Tolerability and Efficacy of JCXH-211 in Patients With Recurrent or Progressive High-Grade Glioma [Phase 1]
The Phase 1 trial of JCXH-211 in patients with recurrent or progressive high-grade glioma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-07-22Clinical Trial Update: A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma [Phase 1]
A Phase 1 clinical trial evaluating bicalutamide with brain re-irradiation for recurrent high-grade glioma/glioblastoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-01-15Clinical Trial Update: Seizures During Radiotherapy for High-grade Gliomas [NA]
A clinical trial studying seizures during radiotherapy for high-grade gliomas has been terminated.
-
CLINICAL_TRIALS withdrawal · 2024-12-04Clinical Trial Update: Study to Assess Xevinapant in Preoperative Subjects With Recurrent High-Grade Glioma (rHGG) [Phase 1]
A Phase 1 trial evaluating Xevinapant in preoperative patients with recurrent high-grade glioma has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-06-06Clinical Trial Update: A Multicenter, Study of the Safety and Pharmacokinetics of Intravenously Infused Berubicin in Pediatric Patients With Progressive, Refractory, or Recurrent High Grade Gliomas [Phase 1]
Phase 1 multicenter trial assessing the safety and pharmacokinetics of intravenously infused berubicin in pediatric patients with progressiv…
-
CLINICAL_TRIALS withdrawal · 2017-02-09Clinical Trial Update: OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade Gliomas [Phase 1]
A Phase 1 pilot trial of OXC401 (fosbretabulin) with bevacizumab for recurrent high-grade gliomas has been withdrawn. The study involves cen…
-
CLINICAL_TRIALS withdrawal · 2015-08-05Clinical Trial Update: Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma [Phase 2]
A Phase 2 trial evaluating carboplatin, temozolomide, and filgrastim for newly diagnosed or recurrent high-grade glioma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2011-09-22Clinical Trial Update: Minimized Time to Beam in Patients With High Grade Gliomas [NA]
The clinical trial NCT00469534 evaluating minimizing time to beam in patients with high-grade glioma has been withdrawn.